Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

Amgen, Xencor Partner
Thursday, September 17, 2015
This deal combines Amgen's proprietary antibodies and Xencor's XmAb® bispecific antibody platform to develop new therapeutic candidates.

Amgen To Acquire Privately-Held Dezima Pharma
Thursday, September 17, 2015
This move strengthens Amgen's cardiovascular portfolio with late-stage, oral CETP inhibitor.

Celgene, Nurix Announce Collaboration
Thursday, September 17, 2015
The two companies are set to work on the discovery, development and commercialization of novel small molecule therapeutics in oncology, inflammation and immunology, including the rapidly evolving field of immunooncology.

Combining Epigenetic Therapies and Immunotherapies Improves Cancer Outcomes
Thursday, September 17, 2015
Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs.

Horizon Enters Licensing Agreement with LakePharma
Thursday, September 17, 2015
The terms of the license cover commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line, developed by Horizon and adapted to manufacturing conditions by LakePharma.

Abzena Acquire PacificGMP
Wednesday, September 16, 2015
Strategic acquisition of GMP biopharmaceutical manufacturing capability in the USA extends service and technology offering, enables the capture of more value from projects, and provides wider cross-selling opportunities across the Group.

Bavarian Nordic Receives Contract From Janssen As Part Of Ebola Vaccine Regimen
Wednesday, September 16, 2015
Total options and awards could amount up to USD 33 million.

Horizon Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc.
Wednesday, September 16, 2015
LakePharma to take a full commercial license for GS null CHO K1 cell line from Horizon for improved efficiency in biopharmaceutical manufacturing.

New Method for Producing Vital Cancer Drug
Tuesday, September 15, 2015
Stanford scientists produced a common cancer drug – previously only available from an endangered plant – in a common laboratory plant.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1613

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos